Cargando…

Beyond the lessons learned from the COVID-19 pandemic: opportunities to optimize clinical trial implementation in oncology

Detalles Bibliográficos
Autores principales:	Castelo-Branco, L., Awada, A., Pentheroudakis, G., Perez-Gracia, J.L., Mateo, J., Curigliano, G., Banerjee, S., Giuliani, R., Lordick, F., Cervantes, A., Tabernero, J., Peters, S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302832/ https://www.ncbi.nlm.nih.gov/pubmed/34411971 http://dx.doi.org/10.1016/j.esmoop.2021.100237

Ejemplares similares

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

ESMO pays tribute to Professor José Baselga
por: Peters, S., et al.
Publicado: (2021)

Learning lessons from the COVID-19 pandemic for real-world evidence research in oncology—shared perspectives from international consortia
por: Castelo-Branco, L., et al.
Publicado: (2023)

Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
por: Curigliano, G., et al.
Publicado: (2020)

Biosimilars: a position paper of the European Society for Medical Oncology, with particular reference to oncology prescribers
por: Tabernero, Josep, et al.
Publicado: (2017)

Career opportunities and benefits for young oncologists in the European Society for Medical Oncology (ESMO)
por: Morgan, Gilberto, et al.
Publicado: (2016)

ESMO Clinical Practice Guidelines: adapting and adopting new approaches for development, implementation and audit
por: Pentheroudakis, G., et al.
Publicado: (2022)

Knowledge and use of biosimilars in oncology: a survey by the European Society for Medical Oncology
por: Giuliani, Rosa, et al.
Publicado: (2019)

Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain
por: Roitberg, F., et al.
Publicado: (2023)

Challenges and knowledge gaps with immune checkpoint inhibitors monotherapy in the management of patients with non-small-cell lung cancer: a survey of oncologist perceptions
por: Castelo-Branco, L., et al.
Publicado: (2023)

Impact of COVID-19 on cancer service delivery: a follow-up international survey of oncology clinicians
por: Chazan, G., et al.
Publicado: (2021)

Current landscape of ESMO/ASCO Global Curriculum adoption and medical oncology recognition: a global survey
por: Cufer, T., et al.
Publicado: (2021)

237P Immune checkpoint inhibitor therapy and outcomes from SARS-CoV-2 infection in patients with cancer: A joint analysis of OnCovid and ESMO-CoCARE registries
por: Cortellini, A., et al.
Publicado: (2022)

The Effects of the COVID-19 Pandemic in Oncology Patient Management
por: Forrester, Mario, et al.
Publicado: (2022)

Biosimilars in oncology
por: Tabernero, Josep
Publicado: (2018)

Identification of an oncological clinical pathway through questionnaires to health professionals
por: Forrester, Mario, et al.
Publicado: (2023)

ESMO Management and treatment adapted recommendations in the COVID-19 era: Pancreatic Cancer
por: Catanese, Silvia, et al.
Publicado: (2020)

Chances, risks and limitations of neoadjuvant therapy in surgical oncology
por: Lordick, Florian, et al.
Publicado: (2016)

Opportunities for Savings in Risk Arrangements for Oncologic Care
por: Landon, Bruce E., et al.
Publicado: (2023)

Oncology clinical trials during the COVID-19 outbreak: Lessons learnt during the crisis and future opportunities
por: Fontana, Elisa, et al.
Publicado: (2020)

Preparing for the incoming wave of biosimilars in oncology
por: Wolff-Holz, Elena, et al.
Publicado: (2018)

Policies beyond the crisis: lesson learned
por: Vogler, Sabine, et al.
Publicado: (2015)

Challenges and Opportunities in Dose Finding in Oncology and Immuno‐oncology
por: Ji, Yan, et al.
Publicado: (2018)

All change: closing the gender gap in oncology
por: Tabernero, Josep
Publicado: (2018)

Digital Health Applications in Oncology: An Opportunity to Seize
por: Parikh, Ravi B, et al.
Publicado: (2022)

Report on the status of women occupying leadership roles in oncology
por: Hofstädter-Thalmann, Eva, et al.
Publicado: (2018)

Malignant circuits: Novel therapeutic opportunities in neuro‐oncology
por: Papavassiliou, Kostas A., et al.
Publicado: (2021)

Palliative Care Beyond Oncology!
por: Bhatnagar, Sushma, et al.
Publicado: (2012)

How I treat endocrine-dependent metastatic breast cancer
por: Gombos, A., et al.
Publicado: (2023)

Assessing cognitive decline in the aging brain: lessons from rodent and human studies
por: Brito, D. V. C., et al.
Publicado: (2023)

Changing the landscape of European School of Oncology–European Society for Medical Oncology masterclasses in clinical oncology during the COVID-19 pandemic
por: Pavlidis, Nicholas, et al.
Publicado: (2022)

COVID-19, a new opportunity for global health education()
por: Romero Trevejo, J.L.
Publicado: (2020)

Challenges and Opportunities to Updating Prescribing Information for Longstanding Oncology Drugs
por: Balogh, Erin P., et al.
Publicado: (2019)

Missed Opportunities in Geriatric Oncology Research
por: Lichtman, Stuart M
Publicado: (2023)

Educational needs in gastrointestinal cancer: a consensus position paper from the ESMO Gastrointestinal Cancer Faculty
por: Lordick, Florian, et al.
Publicado: (2019)

Progress and opportunities in measuring the burden of Chronic Kidney Disease
por: Vart, Priya, et al.
Publicado: (2022)

Mitochondrial pathophysiology beyond the retinal ganglion cell: occipital GABA is decreased in autosomal dominant optic neuropathy
por: d’Almeida, Otília C., et al.
Publicado: (2018)

Clinical and Regulatory Challenges and Opportunities for Monoclonal Antibodies in Low- and Middle-Income Countries: Lessons from COVID-19 and Beyond
por: Gieber, Lisa, et al.
Publicado: (2023)

Opportunities and challenges for the development of “core outcome sets” in neuro-oncology
por: Millward, Christopher P, et al.
Publicado: (2022)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
por: Jardim, Denis L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_sreq92nstm1t19sviks1iuso3i